Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Statin use and risk of Parkinson's disease: a meta-analysis of observational studies.

Undela K, Gudala K, Malla S, Bansal D.

J Neurol. 2013 Jan;260(1):158-65. doi: 10.1007/s00415-012-6606-3. Epub 2012 Jul 21.

PMID:
22820685
2.

Statin use and risk of prostate cancer: a meta-analysis of observational studies.

Bansal D, Undela K, D'Cruz S, Schifano F.

PLoS One. 2012;7(10):e46691. doi: 10.1371/journal.pone.0046691. Epub 2012 Oct 1.

3.

Statin use and risk of breast cancer: a meta-analysis of observational studies.

Undela K, Srikanth V, Bansal D.

Breast Cancer Res Treat. 2012 Aug;135(1):261-9. doi: 10.1007/s10549-012-2154-x. Epub 2012 Jul 18.

PMID:
22806241
4.

Statin use and risk of bladder cancer: a meta-analysis.

Zhang XL, Geng J, Zhang XP, Peng B, Che JP, Yan Y, Wang GC, Xia SQ, Wu Y, Zheng JH.

Cancer Causes Control. 2013 Apr;24(4):769-76. doi: 10.1007/s10552-013-0159-3. Epub 2013 Jan 30.

PMID:
23361339
5.

Statin use and risk of Parkinson's disease: A meta-analysis.

Sheng Z, Jia X, Kang M.

Behav Brain Res. 2016 Aug 1;309:29-34. doi: 10.1016/j.bbr.2016.04.046. Epub 2016 Apr 27.

PMID:
27131781
6.

Use of statins and breast cancer: a meta-analysis of seven randomized clinical trials and nine observational studies.

Bonovas S, Filioussi K, Tsavaris N, Sitaras NM.

J Clin Oncol. 2005 Dec 1;23(34):8606-12. Epub 2005 Oct 31.

7.

Statin use and risk of kidney cancer: a meta-analysis of observational studies and randomized trials.

Zhang XL, Liu M, Qian J, Zheng JH, Zhang XP, Guo CC, Geng J, Peng B, Che JP, Wu Y.

Br J Clin Pharmacol. 2014 Mar;77(3):458-65. doi: 10.1111/bcp.12210. Review.

8.

Statin use and risk of lung cancer: a meta-analysis of observational studies and randomized controlled trials.

Wang J, Li C, Tao H, Cheng Y, Han L, Li X, Hu Y.

PLoS One. 2013 Oct 25;8(10):e77950. doi: 10.1371/journal.pone.0077950. eCollection 2013.

9.

Statin use is associated with reduced risk of haematological malignancies: evidence from a meta-analysis.

Yi X, Jia W, Jin Y, Zhen S.

PLoS One. 2014 Jan 31;9(1):e87019. doi: 10.1371/journal.pone.0087019. eCollection 2014.

10.

Meta-analysis of the effect of statins on mortality in patients with preserved ejection fraction.

Liu G, Zheng XX, Xu YL, Ru J, Hui RT, Huang XH.

Am J Cardiol. 2014 Apr 1;113(7):1198-204. doi: 10.1016/j.amjcard.2013.12.023. Epub 2014 Jan 14. Review.

PMID:
24513478
11.

Statin Use and the Risk of Parkinson's Disease: An Updated Meta-Analysis.

Bai S, Song Y, Huang X, Peng L, Jia J, Liu Y, Lu H.

PLoS One. 2016 Mar 28;11(3):e0152564. doi: 10.1371/journal.pone.0152564. eCollection 2016.

12.

Use of statins in primary and secondary prevention of coronary heart disease and ischemic stroke. Meta-analysis of randomized trials.

Vrecer M, Turk S, Drinovec J, Mrhar A.

Int J Clin Pharmacol Ther. 2003 Dec;41(12):567-77.

PMID:
14692706
13.

Use of statins and risk of haematological malignancies: a meta-analysis of six randomized clinical trials and eight observational studies.

Bonovas S, Filioussi K, Tsantes A, Sitaras NM.

Br J Clin Pharmacol. 2007 Sep;64(3):255-62. Epub 2007 Jun 19. Review.

14.

Effect of statin on risk of gynecologic cancers: a meta-analysis of observational studies and randomized controlled trials.

Liu Y, Qin A, Li T, Qin X, Li S.

Gynecol Oncol. 2014 Jun;133(3):647-55. doi: 10.1016/j.ygyno.2014.04.007. Epub 2014 Apr 13.

PMID:
24736024
15.

Statins and cancer risk: a literature-based meta-analysis and meta-regression analysis of 35 randomized controlled trials.

Bonovas S, Filioussi K, Tsavaris N, Sitaras NM.

J Clin Oncol. 2006 Oct 20;24(30):4808-17. Epub 2006 Sep 25.

16.

Caffeine exposure and the risk of Parkinson's disease: a systematic review and meta-analysis of observational studies.

Costa J, Lunet N, Santos C, Santos J, Vaz-Carneiro A.

J Alzheimers Dis. 2010;20 Suppl 1:S221-38. doi: 10.3233/JAD-2010-091525. Review.

PMID:
20182023
17.

Statin use and risk of pancreatic cancer: a meta-analysis.

Cui X, Xie Y, Chen M, Li J, Liao X, Shen J, Shi M, Li W, Zheng H, Jiang B.

Cancer Causes Control. 2012 Jul;23(7):1099-111. doi: 10.1007/s10552-012-9979-9. Epub 2012 May 5.

PMID:
22562222
18.

Association between statin use and colorectal cancer risk: a meta-analysis of 42 studies.

Liu Y, Tang W, Wang J, Xie L, Li T, He Y, Deng Y, Peng Q, Li S, Qin X.

Cancer Causes Control. 2014 Feb;25(2):237-49. doi: 10.1007/s10552-013-0326-6. Epub 2013 Nov 22.

PMID:
24265089
19.

Prospective study of statin use and risk of Parkinson disease.

Gao X, Simon KC, Schwarzschild MA, Ascherio A.

Arch Neurol. 2012 Mar;69(3):380-4. doi: 10.1001/archneurol.2011.1060.

20.

Statins and the risk of lung cancer: a meta-analysis.

Tan M, Song X, Zhang G, Peng A, Li X, Li M, Liu Y, Wang C.

PLoS One. 2013;8(2):e57349. doi: 10.1371/journal.pone.0057349. Epub 2013 Feb 28.

Items per page

Supplemental Content

Write to the Help Desk